Stock VEN VENTAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ventas, Inc. Deutsche Boerse AG

Equities

VEN

US92276F1003

Specialized REITs

Real-time Estimate Tradegate
Other stock markets
 01:24:21 2024-05-24 pm EDT 		5-day change 1st Jan Change
44.18 EUR -0.95% Intraday chart for Ventas, Inc. -2.64% -4.38%
May. 20 BMO Capital Adjusts Ventas Price Target to $53 From $51 MT
May. 16 Scotiabank Adjusts Price Target on Ventas to $51 From $47 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 21,522 18,369 20,406 18,007 20,041 19,067 - -
Enterprise Value (EV) 1 33,574 29,813 32,284 30,182 33,023 31,937 32,070 31,989
P/E ratio 49.4 x 41.9 x 393 x -375 x -498 x -211 x 3,119 x 101 x
Yield 5.49% 4.37% 3.52% 4% 3.61% 3.83% 4.04% 4.42%
Capitalization / Revenue 5.56 x 4.84 x 5.33 x 4.36 x 4.46 x 3.95 x 3.74 x 3.62 x
EV / Revenue 8.67 x 7.86 x 8.43 x 7.31 x 7.34 x 6.61 x 6.29 x 6.07 x
EV / EBITDA 17.2 x 16.1 x 19.5 x 17.3 x 18 x 16.8 x 15.6 x 14.5 x
EV / FCF 38.3 x - - - - 47.5 x 38.1 x 34.6 x
FCF Yield 2.61% - - - - 2.1% 2.63% 2.89%
Price to Book 2.02 x 1.8 x 1.88 x 1.77 x 2.13 x 2.1 x 2.73 x 3.09 x
Nbr of stocks (in thousands) 372,736 374,571 399,176 399,718 402,104 404,049 - -
Reference price 2 57.74 49.04 51.12 45.05 49.84 47.19 47.19 47.19
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,873 3,795 3,828 4,129 4,498 4,830 5,098 5,271
EBITDA 1 1,955 1,856 1,656 1,744 1,834 1,898 2,054 2,213
EBIT 1 909.8 746.7 459 545.7 441.6 644.8 705.2 918.5
Operating Margin 23.49% 19.67% 11.99% 13.22% 9.82% 13.35% 13.83% 17.43%
Earnings before Tax (EBT) 1 359.4 344.7 61.39 -64.37 -50.51 46.31 161.6 295.2
Net income 1 433 439.1 49.01 -47.45 -40.97 -74.33 -14.22 72.65
Net margin 11.18% 11.57% 1.28% -1.15% -0.91% -1.54% -0.28% 1.38%
EPS 2 1.170 1.170 0.1300 -0.1200 -0.1000 -0.2233 0.0151 0.4650
Free Cash Flow 1 877.1 - - - - 672 842.1 925.4
FCF margin 22.65% - - - - 13.91% 16.52% 17.56%
FCF Conversion (EBITDA) 44.86% - - - - 35.4% 41% 41.82%
FCF Conversion (Net income) 202.56% - - - - - - 1,273.87%
Dividend per Share 2 3.170 2.142 1.800 1.800 1.800 1.807 1.908 2.086
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,022 1,018 1,023 1,037 1,051 1,077 1,106 1,150 1,164 1,200 1,192 1,214 1,230 1,244 1,251
EBITDA 1 405.3 431.2 416.4 438.4 441.4 432.2 459.8 469.9 472.1 477.1 478.2 487.9 494 494.7 517.4
EBIT 1 86.36 142.2 133.3 136.9 117.2 150.1 155.2 99.51 36.82 176.8 142.2 141.5 140.9 146.2 -
Operating Margin 8.45% 13.97% 13.03% 13.2% 11.15% 13.93% 14.02% 8.65% 3.16% 14.74% 11.93% 11.66% 11.46% 11.75% -
Earnings before Tax (EBT) 1 - - - - - - - - - -15.54 22.38 14 17.43 21.51 44.2
Net income 1 -40.85 38.73 -42.42 1.256 -45.02 17.52 103.5 -71.12 -90.82 -14.31 -20.15 -25.39 -26.47 -39.6 -23.67
Net margin -4% 3.81% -4.15% 0.12% -4.28% 1.63% 9.35% -6.19% -7.8% -1.19% -1.69% -2.09% -2.15% -3.18% -1.89%
EPS 2 -0.1000 0.1000 -0.1100 - -0.1100 0.0400 0.2600 -0.1800 -0.2300 -0.0400 -0.0680 -0.0540 -0.0520 -0.0833 -0.0436
Dividend per Share 2 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4538 0.4554 0.4835 0.5036
Announcement Date 2/17/22 5/5/22 8/4/22 11/3/22 2/9/23 5/8/23 8/3/23 11/2/23 2/14/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 12,052 11,444 11,878 12,174 12,982 12,870 13,003 12,922
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 6.164 x 6.164 x 7.171 x 6.983 x 7.078 x 6.781 x 6.33 x 5.84 x
Free Cash Flow 1 877 - - - - 672 842 925
ROE (net income / shareholders' equity) 4.19% 4.26% 0.47% -0.45% -0.42% 0.38% 0.76% 2.76%
ROA (Net income/ Total Assets) 1.83% 1.81% 0.2% -0.19% -0.17% - 0.07% 0.61%
Assets 1 23,638 24,311 24,324 24,457 24,102 - -19,250 11,931
Book Value Per Share 2 28.50 27.20 27.20 25.40 23.40 22.40 17.30 15.30
Cash Flow per Share 2 3.890 3.850 2.660 2.780 2.760 3.180 3.510 3.860
Capex 1 561 529 433 454 643 211,884 234,561 -
Capex / Sales 14.48% 13.93% 11.31% 11% 14.3% 4,387.09% 4,600.68% -
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Ventas, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
47.19 USD
Average target price
53.5 USD
Spread / Average Target
+13.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

1st Jan change Capi.
WELLTOWER INC. Stock Welltower Inc.
+11.80% 59.77B
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-3.36% 13.4B
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+2.41% 7.74B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-7.31% 5.89B
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+13.43% 3.59B
AEDIFICA SA Stock Aedifica SA
-6.99% 3.04B
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
+2.55% 3.03B
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+16.29% 2.8B
COFINIMMO Stock Cofinimmo
-16.11% 2.35B
Healthcare REITs
  1. Stock Market
  2. Equities
  3. VTR Stock
  4. VEN Stock
  5. Financials Ventas, Inc.